Research
Hormonal
GLP-1 exerts protective effects on musculoskeletal tissues (bone, cartilage, muscle, disc) by reducing inflammation, oxidative stress, and apoptosis.
Maintaining healthy GLP-1 levels (via gut health) may help protect joints and muscles from age-related degeneration by reducing inflammation and cell death.
ModerateSupportsMEDIUM confidence
Mechanistically, GLP-1 signaling mitigates tissue degeneration by modulating nuclear factor kappa B (NF-κB), reactive oxygen species (ROS), and B-cell lymphoma 2 (Bcl-2) pathways, thereby driving critical anti-inflammatory, antioxidant, and anti-apoptotic processes.
Why this rating
Review of multiple preclinical and clinical studies.
Source
Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases
Wenxing Yang et al. · Gut Microbes · 2026
DOI 10.1080/19490976.2026.2661854
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Specific gut microbial metabolites (SCFAs, Bile Acids, Tryptophan derivatives) stimulate GLP-1 secretion from intestinal L cells via specific receptors (FFAR2/3, TGR5, GPR142).Good
- Gut microbiota dysbiosis impairs GLP-1 secretion, contributing to the progression of degenerative musculoskeletal diseases (osteoarthritis, osteoporosis, sarcopenia, and intervertebral disc degeneration).Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →